FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033233914> ?p ?o ?g. }

• W3033233914 endingPage "533" @default.
• W3033233914 startingPage "529" @default.
• W3033233914 abstract "Abstract Purpose To investigate the optimal contact time and concentration for viricidal activity of oral preparation of povidone‐iodine (PVP‐I) against SARS‐CoV‐2 (‘corona virus’) to mitigate the risk and transmission of the virus in the dental practice. Materials and Methods The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) USA‐WA1/2020 strain, virus stock was tested against oral antiseptic solutions consisting of aqueous povidone‐iodine (PVP‐I) as the sole active ingredient. The PVP‐I was tested at diluted concentrations of 0.5%, 1%, and 1.5%. Test media without any virus was added to 2 tubes of the compounds to serve as toxicity and neutralization controls. Ethanol (70%) was tested in parallel as a positive control, and water only as a negative control. The test solutions and virus were incubated at room temperature (22 ± 2 °C) for time periods of 15 and 30 seconds. The solution was then neutralized by a 1/10 dilution in minimum essential medium (MEM) 2% fetal bovine serum (FBS), 50 µg/mL gentamicin. Surviving virus from each sample was quantified by standard end‐point dilution assay and the log reduction value (LRV) of each compound compared to the negative (water) control was calculated. Results PVP‐I oral antiseptics at all tested concentrations of 0.5%, 1%, and 1.5%, completely inactivated SARS‐CoV‐2 within 15 seconds of contact. The 70% ethanol control group was unable to completely inactivate SARS‐CoV‐2 after 15 seconds of contact, but was able to inactivate the virus at 30 seconds of contact. Conclusions PVP‐I oral antiseptic preparations rapidly inactivated SARS‐CoV‐2 virus in vitro. The viricidal activity was present at the lowest concentration of 0.5 % PVP‐I and at the lowest contact time of 15 seconds. This important finding can justify the use of preprocedural oral rinsing with PVP‐I (for patients and health care providers) may be useful as an adjunct to personal protective equipment, for dental and surgical specialties during the COVID‐19 pandemic." @default.
• W3033233914 created "2020-06-12" @default.
• W3033233914 creator A5000464344 @default.
• W3033233914 creator A5021112650 @default.
• W3033233914 creator A5034219414 @default.
• W3033233914 creator A5043700007 @default.
• W3033233914 creator A5052207768 @default.
• W3033233914 creator A5082488663 @default.
• W3033233914 date "2020-06-16" @default.
• W3033233914 modified "2023-10-18" @default.
• W3033233914 title "Rapid In‐Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) Using Povidone‐Iodine Oral Antiseptic Rinse" @default.
• W3033233914 cites W1820067682 @default.
• W3033233914 cites W2003149669 @default.
• W3033233914 cites W2032843753 @default.
• W3033233914 cites W2035047172 @default.
• W3033233914 cites W2074244499 @default.
• W3033233914 cites W2079093802 @default.
• W3033233914 cites W2109180072 @default.
• W3033233914 cites W2119013266 @default.
• W3033233914 cites W2129667078 @default.
• W3033233914 cites W2256756668 @default.
• W3033233914 cites W2542491629 @default.
• W3033233914 cites W2755563760 @default.
• W3033233914 cites W2796759435 @default.
• W3033233914 cites W2974981625 @default.
• W3033233914 cites W2999318660 @default.
• W3033233914 cites W3005057892 @default.
• W3033233914 cites W3006961006 @default.
• W3033233914 cites W3011483298 @default.
• W3033233914 cites W3012246159 @default.
• W3033233914 cites W3033509828 @default.
• W3033233914 cites W3035177636 @default.
• W3033233914 cites W32503470 @default.
• W3033233914 doi "https://doi.org/10.1111/jopr.13209" @default.
• W3033233914 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7300649" @default.
• W3033233914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32511851" @default.
• W3033233914 hasPublicationYear "2020" @default.
• W3033233914 type Work @default.
• W3033233914 sameAs 3033233914 @default.
• W3033233914 citedByCount "119" @default.
• W3033233914 countsByYear W30332339142020 @default.
• W3033233914 countsByYear W30332339142021 @default.
• W3033233914 countsByYear W30332339142022 @default.
• W3033233914 countsByYear W30332339142023 @default.
• W3033233914 crossrefType "journal-article" @default.
• W3033233914 hasAuthorship W3033233914A5000464344 @default.
• W3033233914 hasAuthorship W3033233914A5021112650 @default.
• W3033233914 hasAuthorship W3033233914A5034219414 @default.
• W3033233914 hasAuthorship W3033233914A5043700007 @default.
• W3033233914 hasAuthorship W3033233914A5052207768 @default.
• W3033233914 hasAuthorship W3033233914A5082488663 @default.
• W3033233914 hasBestOaLocation W30332339141 @default.
• W3033233914 hasConcept C121332964 @default.
• W3033233914 hasConcept C126322002 @default.
• W3033233914 hasConcept C14086860 @default.
• W3033233914 hasConcept C143432726 @default.
• W3033233914 hasConcept C159047783 @default.
• W3033233914 hasConcept C178790620 @default.
• W3033233914 hasConcept C185592680 @default.
• W3033233914 hasConcept C199343813 @default.
• W3033233914 hasConcept C2522874641 @default.
• W3033233914 hasConcept C2777084678 @default.
• W3033233914 hasConcept C2777648638 @default.
• W3033233914 hasConcept C2779134260 @default.
• W3033233914 hasConcept C2781460226 @default.
• W3033233914 hasConcept C3008058167 @default.
• W3033233914 hasConcept C31903555 @default.
• W3033233914 hasConcept C524204448 @default.
• W3033233914 hasConcept C539932907 @default.
• W3033233914 hasConcept C71924100 @default.
• W3033233914 hasConcept C86803240 @default.
• W3033233914 hasConcept C89423630 @default.
• W3033233914 hasConcept C96618451 @default.
• W3033233914 hasConcept C97355855 @default.
• W3033233914 hasConceptScore W3033233914C121332964 @default.
• W3033233914 hasConceptScore W3033233914C126322002 @default.
• W3033233914 hasConceptScore W3033233914C14086860 @default.
• W3033233914 hasConceptScore W3033233914C143432726 @default.
• W3033233914 hasConceptScore W3033233914C159047783 @default.
• W3033233914 hasConceptScore W3033233914C178790620 @default.
• W3033233914 hasConceptScore W3033233914C185592680 @default.
• W3033233914 hasConceptScore W3033233914C199343813 @default.
• W3033233914 hasConceptScore W3033233914C2522874641 @default.
• W3033233914 hasConceptScore W3033233914C2777084678 @default.
• W3033233914 hasConceptScore W3033233914C2777648638 @default.
• W3033233914 hasConceptScore W3033233914C2779134260 @default.
• W3033233914 hasConceptScore W3033233914C2781460226 @default.
• W3033233914 hasConceptScore W3033233914C3008058167 @default.
• W3033233914 hasConceptScore W3033233914C31903555 @default.
• W3033233914 hasConceptScore W3033233914C524204448 @default.
• W3033233914 hasConceptScore W3033233914C539932907 @default.
• W3033233914 hasConceptScore W3033233914C71924100 @default.
• W3033233914 hasConceptScore W3033233914C86803240 @default.
• W3033233914 hasConceptScore W3033233914C89423630 @default.
• W3033233914 hasConceptScore W3033233914C96618451 @default.
• W3033233914 hasConceptScore W3033233914C97355855 @default.
• W3033233914 hasIssue "6" @default.
• W3033233914 hasLocation W30332339141 @default.

• next